Monte Rosa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	125.58	128.1	54.91	346.07	41.7	6
Short-Term Investments	116.61	104.31	207.91	-	-	-
Cash & Short-Term Investments	242.19	232.41	262.83	346.07	41.7	6
Cash Growth	35.70%	-11.57%	-24.05%	729.93%	595.56%	-
Other Receivables	-	0.51	7.66	-	0.1	0.05
Receivables	0.6	0.51	7.66	-	0.1	0.05
Prepaid Expenses	8.43	3.29	4.44	2.6	1.79	0.46
Restricted Cash	-	-	0.96	-	-	3.25
Total Current Assets	251.21	236.21	275.89	348.67	43.59	9.76
Property, Plant & Equipment	58.81	62.61	61.91	12.33	4.62	1.34
Other Long-Term Assets	5.07	4.93	4.6	5.34	1.16	-
Total Assets	315.08	303.76	342.39	366.33	49.38	11.09
Accounts Payable	3.98	11.15	7.86	6.56	7.07	3.2
Accrued Expenses	13.8	12.93	9.56	9.24	1.13	-
Short-Term Debt	-	-	-	-	-	0.75
Current Portion of Leases	3.65	3.16	3.13	-	-	-
Current Unearned Revenue	18.92	17.68	-	-	-	-
Other Current Liabilities	1.3	1.67	5.02	0.84	21.08	0.35
Total Current Liabilities	41.64	46.59	25.57	16.64	29.28	4.29
Long-Term Leases	40.05	42.88	43.87	-	-	-
Long-Term Unearned Revenue	25.11	32.32	-	-	-	-
Total Liabilities	109.62	124.51	70.98	18.81	30.34	4.29
Common Stock	0.01	0.01	0.01	0.01	0	0.05
Additional Paid-In Capital	659.8	547.86	503.7	471.57	0.4	-
Retained Earnings	-452.03	-365.89	-230.54	-122.04	-48.08	-12.2
Comprehensive Income & Other	-2.32	-2.72	-1.75	-2.02	-1.06	-
Total Common Equity	205.46	179.25	271.41	347.52	-48.73	-12.15
Shareholders' Equity	205.46	179.25	271.41	347.52	19.04	6.8
Total Liabilities & Equity	315.08	303.76	342.39	366.33	49.38	11.09
Total Debt	43.7	46.04	47	-	-	0.75
Net Cash (Debt)	198.49	186.37	215.83	346.07	41.7	5.25
Net Cash Growth	50.28%	-13.65%	-37.64%	729.93%	695.02%	-
Net Cash Per Share	2.94	3.63	4.57	13.84	27.49	3.70
Filing Date Shares Outstanding	61.44	50.14	49.24	46.37	1.69	1.42
Total Common Shares Outstanding	61.38	50.14	49.32	46.54	1.69	1.42
Working Capital	209.57	189.62	250.32	332.03	14.32	5.47
Book Value Per Share	3.35	3.57	5.50	7.47	-28.91	-8.58
Tangible Book Value	205.46	179.25	271.41	347.52	-48.73	-12.15
Tangible Book Value Per Share	3.35	3.57	5.50	7.47	-28.91	-8.58
Machinery	27.31	24.23	18.65	13.06	5.23	1.41
Construction In Progress	0.13	0.92	12.01	0.85	-	-
Leasehold Improvements	22.31	20.89	2.66	1.12	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.